We are live on ! Find out more
MLNT

Melinta Therapeutics, Inc. Common Stock
MLNT

Delisted

MLNT was delisted on the 10th of January, 2020.

Back to rankings

78 hedge funds and large institutions have $183M invested in Melinta Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 78 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

35% less call options, than puts

Call options by funds: $1.85M | Put options by funds: $2.84M

Holders
78
Holders Change
+78
Holders Change %
–
% of All Funds
1.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
78
Increased
–
Reduced
–
Closed
–
Calls
$1.85M
Puts
$2.84M
Net Calls
-$985K
Net Calls Change
-$985K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.6M
2
BlackRock
BlackRock
New York
+$8.95M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$7.73M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$6.37M
5
Millennium Management
Millennium Management
New York
+$4.13M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
51
UBS Group
Switzerland
$59K +$56K +757 New
Legal & General Group
52
Legal & General Group
United Kingdom
$43K +$40.3K +544 New
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
$42.1K +$39.4K +533 New
SO
54
STRS Ohio
Ohio
$42K +$40K +540 New
Federated Hermes
55
Federated Hermes
Pennsylvania
$39K +$36.1K +488 New
Public Employees Retirement Association of Colorado
56
Public Employees Retirement Association of Colorado
Colorado
$39K +$36.6K +495 New
JP Morgan Chase
57
JP Morgan Chase
New York
$36K +$33.7K +455 New
Citigroup
58
Citigroup
New York
$33K +$31.7K +428 New
Northwestern Mutual Wealth Management
59
Northwestern Mutual Wealth Management
Wisconsin
$28K +$26K +351 New
Parallax Volatility Advisers
60
Parallax Volatility Advisers
California
$23K +$21.8K +294 New
AIP
61
Ameritas Investment Partners
Nebraska
$12K +$11.4K +154 New
MAM
62
Meeder Asset Management
Ohio
$11K +$10.7K +145 New
Royal Bank of Canada
63
Royal Bank of Canada
Ontario, Canada
$10K +$9.4K +127 New
TRCT
64
Tower Research Capital (TRC)
New York
$9K +$8.88K +120 New
MA
65
MCF Advisors
Kentucky
$6K +$5.92K +80 New
LTFS
66
Ladenburg Thalmann Financial Services
Florida
$4K +$3.63K +49 New
FANJ
67
Financial Architects (New Jersey)
New Jersey
$3K +$2.37K +32 New
AG
68
Advisor Group
Arizona
$3K +$2.96K +40 New
AF
69
Advisornet Financial
Minnesota
$3K +$2.96K +40 New
CCM
70
Covington Capital Management
California
$3K +$2.96K +40 New
PNC Financial Services Group
71
PNC Financial Services Group
Pennsylvania
$2K +$962 +13 New
SIAP
72
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$2K +$1.41K +19 New
TFA
73
Toth Financial Advisory
Virginia
$1K +$888 +12 New
VCM
74
Versant Capital Management
Arizona
– +$296 +4 New
Macquarie Group
75
Macquarie Group
Australia
– +$370 +5 New
1 2
3
4

MLNT Hedge Fund Activity: Q4 2017 in Review

78 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Melinta Therapeutics, Inc. Common Stock (MLNT) for Q4 2017, worth a combined $183M.

Buyers outnumbered sellers: 78 funds opened new MLNT positions and 0 closed out — a net gain of 78 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $14.6M.

  • 78 institutional investors held Melinta Therapeutics, Inc. Common Stock (MLNT) as of Q4 2017, up from 0 in Q3 2017.
  • Funds reported $183M of Melinta Therapeutics, Inc. Common Stock stock for Q4 2017.
  • 78 funds opened new Melinta Therapeutics, Inc. Common Stock positions in Q4 2017 and 0 closed out, a net change of +78 holders.
  • The largest Melinta Therapeutics, Inc. Common Stock buyer in Q4 2017 was Fidelity Investments, an estimated $14.6M added.

Based on aggregated 13F filings for Q4 2017.